Azalea Therapeutics

Biotechnology · Berkeley, CA · Founded 2023 · Privately Held (backing)

Operator of a biotechnology platform intended to enable precise genome editing inside the body for disease treatment. Azalea Therapeutics is based in Berkeley, CA and was founded in 2023. It was valued at $153 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $82 million across 1 recorded round; the latest was a $65 million Series A in Oct 2025.

PMV mark · valuation
$153.0M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$82.0M
Last round
Early Stage VC (Series A)
Oct 2025
How much has Azalea Therapeutics raised?
$82.0Macross 1 recorded rounds · Oct 2025 – Oct 2025

Most recently, Azalea Therapeutics raised $65.0M in its Early Stage VC (Series A) (Oct 2025).

Free account
More of Azalea Therapeutics with a free account
  • ·Watch Azalea Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Azalea Therapeutics round by round

1 rounds
Oct 2025Early Stage VC (Series A)$65.0M▮
+ 1 more investors · free account

How much has Azalea Therapeutics raised?

Azalea Therapeutics has raised $82 million in total; 1 of its rounds is on record. The largest on record was a $65 million Series A in Oct 2025.

Azalea Therapeutics investors

6 investors are on record for Azalea Therapeutics, including RA Capital Management, University of California, Sozo Ventures and Third Rock Ventures. The Series A in Oct 2025 drew 3 investors.

For fundraisers
Raising for a company like Azalea Therapeutics?

6 investors have backed Azalea Therapeutics — start your target list with the firms already writing checks in biotechnology.

See all 6 investors →

Frequently asked about Azalea Therapeutics

How much has Azalea Therapeutics raised?
Azalea Therapeutics has raised $82.0M in total across 1 recorded funding rounds.
When was Azalea Therapeutics's last funding round?
Azalea Therapeutics's most recent recorded round was Early Stage VC (Series A) in Oct 2025, raising $65.0M.